Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and the National Lung Cancer Partnership
Prasad Adusumilli, PhD
Memorial Sloan Kettering Cancer Center
New York
NY
Dr. Adusumilli is studying patients who underwent surgery for early-stage lung cancer but whose lung cancer returned because of a condition in which the cancer extends to the pleural membrane covering the lung cancer. Using genetic engineering, Dr. Adusumilli is modifying the patient’s own immune cells in a way that may not only eliminate the spread of tumor cells to the pleura but may also treat the spread of the cancer by tumors too small to be detected.